Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy.
Crews L, Spencer B, Desplats P, Patrick C, Paulino A, Rockenstein E, Hansen L, Adame A, Galasko D, Masliah E. · 2010
Read Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy. by Crews L, Spencer B, Desplats P, Patrick C, Paulino A, Rockenstein E, Hansen L, Adame A, Galasko D, Masliah E. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2824828.txt.
Description
Crews and colleagues examined the cell's recycling system in 2010 in brains from patients with Lewy body disease, a group of disorders marked by clumps of a protein called alpha-synuclein. The recycling system, autophagy, is a main route for clearing that protein, so faults in it could let clumps build.
Compared with healthy and Alzheimer brains, patient brains showed more of a brake protein called mTor and less of a recycling gear called Atg7, while other gears stayed level. Neurons stuffed with alpha-synuclein held the most mTor and showed swollen, abnormal recycling sacs. Mice engineered to overproduce the protein showed the same pattern. In those mice, a brake-lifting drug or extra Atg7 cut the protein buildup and eased brain cell damage.
Catalog record
| CREATOR | Crews L, Spencer B, Desplats P, Patrick C, Paulino A, Rockenstein E, Hansen L, Adame A, Galasko D, Masliah E. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 74 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |